Episode 521: ESMO 2026 - Reconciling Discrepant Results of Neoadjuvant Chemotherapy + IO in MIBC

Episode 521: ESMO 2026 - Reconciling Discrepa...

Up next

Episode 523: ESMO 2026: ctDNA Kinetics from Neoadjuvant EVP in MIBC

Jon Chatzkel joins us after his ESMO 2026 presentation to discuss ctDNA results from the KEYNOTE 905 trial. 

Episode 522: ESMO 2026 - KEYNOTE-905 Analysis of Neoadjuvant EVP or Pembro Monotherapy in Cis-ineligible MIBC

Anders Ullen joins the show after his EMSO 2026 presentation looking at KN-905 for the period in which Cis-ineligible MIBC patients were randomized to immediate cystectomy vs neoadjuvant Pembro or EVP. 

Recommended Episodes

Cancer and Exercise - Let’s beat it together. EP #563
BJSM Podcast

In this episode Dr Kyle Winik is joined by Dr Lervasen Pillay, a Sport and Exercise Physician who has a keen interest in Exercise and Cancer. Through the episode they discuss an approach to a patient battling cancer and try to give an approach to change the narrative that exercis ...  Show more

Beating Prostate Cancer
Nutrition Facts with Dr. Greger

New research on prostate cancer screening and diet. This episode features audio from: The Pros and Cons of Testing PSA Levels for Prostate Cancer Changing a Man’s Diet After a Prostate Cancer Diagnosis Natural Dietary Treatments for Enlarged Prostate BPH Visit the video pages for ...  Show more

S7 E3: Anti-Ds side effects; knee OA exercise; PSA trends & PCUK interview with Dr Bunmi Olajide & Kevin Howell
NB Hot Topics Podcast

Welcome back to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we look at three new pieces of research and have a special interview in conjunction with Prostate Cancer UK. First, do antidepressants have physiological side effects? How do they compare ...  Show more